Literature DB >> 7520206

The inflammatory lesion of T cell line transferred experimental autoimmune encephalomyelitis of the Lewis rat: distinct nature of parenchymal and perivascular infiltrates.

J Lannes-Vieira1, J Gehrmann, G W Kreutzberg, H Wekerle.   

Abstract

We have investigated the T cell receptor (TCR) repertoire in the inflammatory infiltrates of T line-transferred experimental autoimmune encephalomyelitis (EAE) of the Lewis rats. Using a panel of TCR V beta-specific monoclonal antibodies (mAbs) and immunocytochemistry, we studied the nature of the T cells entering the central nervous system (CNS) after transfer of either myelin basic protein (MBP)-reactive, or MBP-reactive but non-encephalitogenic T cell lines. All the MBP-specific T cell lines predominantly used the V beta 8.2 TCR chain. T cell lines specific for the tuberculin purified protein derivative (PPD), using TCR V genes different from V beta 8.2, served as controls. We first studied the time course of T cells entering the CNS. In all recipient rats, small, but significant numbers of alpha beta-TCR-expressing infiltrate cells appeared in the CNS within the first 24 h after T cell transfer. In animals injected with either type of MBP-reactive T cells, the early infiltrate cells were preferentially located within the parenchyma of the spinal cord, while in PDD T line-injected rats, the lymphocytes were mostly found in the meninges. TCR V beta gene usage was examined on the peak of clinical disease. Six days after T cell transfer, the TCR repertoire used by infiltrating lymphocytes in general seemed to be highly diverse. None of the V beta isotypes examined (i.e. V beta 8.2, V beta 8.5 or V beta 10) was used by a major population of the alpha beta-TCR-positive T cells.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520206     DOI: 10.1007/bf00294169

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

1.  V beta repertoire in rats and implications for endogenous superantigens.

Authors:  L R Smith; D H Kono; M E Kammuller; R S Balderas; A N Theofilopoulos
Journal:  Eur J Immunol       Date:  1992-03       Impact factor: 5.532

2.  T-lymphocyte entry into the central nervous system.

Authors:  W F Hickey; B L Hsu; H Kimura
Journal:  J Neurosci Res       Date:  1991-02       Impact factor: 4.164

3.  Homing of Lyt-2+ and Lyt-2- T cell subsets and B lymphocytes to the central nervous system of mice with acute experimental allergic encephalomyelitis.

Authors:  J Trotter; L Steinman
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

4.  Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis.

Authors:  B L Kotzin; S Karuturi; Y K Chou; J Lafferty; J M Forrester; M Better; G E Nedwin; H Offner; A A Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions.

Authors:  R A Sobel; V K Kuchroo
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

6.  In situ demonstration of proliferating cells in the rat central nervous system during experimental autoimmune encephalomyelitis. Evidence suggesting that most infiltrating T cells do not proliferate in the target organ.

Authors:  K Ohmori; Y Hong; M Fujiwara; Y Matsumoto
Journal:  Lab Invest       Date:  1992-01       Impact factor: 5.662

7.  Limited heterogeneity of rearranged T-cell receptor V alpha transcripts in brains of multiple sclerosis patients.

Authors:  J R Oksenberg; S Stuart; A B Begovich; R B Bell; H A Erlich; L Steinman; C C Bernard
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

8.  Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor and recipient animals.

Authors:  R J Fallis; M L Powers; M S Sy; H L Weiner
Journal:  J Neuroimmunol       Date:  1987-03       Impact factor: 3.478

9.  T cell receptor V alpha-V beta repertoire and cytokine gene expression in active multiple sclerosis lesions.

Authors:  K W Wucherpfennig; J Newcombe; H Li; C Keddy; M L Cuzner; D A Hafler
Journal:  J Exp Med       Date:  1992-04-01       Impact factor: 14.307

10.  A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes.

Authors:  T Hünig; H J Wallny; J K Hartley; A Lawetzky; G Tiefenthaler
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Immune control of the brain.

Authors:  M Bradl
Journal:  Springer Semin Immunopathol       Date:  1996

2.  T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR beta-chain-variable-region V beta 8.2-positive T cells are not essential for induction and course of disease.

Authors:  R Gold; G Giegerich; H P Hartung; K V Toyka
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

3.  Prevention of axonal injury using calpain inhibitor in chronic progressive experimental autoimmune encephalomyelitis.

Authors:  Getaw Worku Hassen; Jason Feliberti; Leo Kesner; Alfred Stracher; Foroozan Mokhtarian
Journal:  Brain Res       Date:  2008-08-12       Impact factor: 3.252

4.  Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction.

Authors:  H Babbe; A Roers; A Waisman; H Lassmann; N Goebels; R Hohlfeld; M Friese; R Schröder; M Deckert; S Schmidt; R Ravid; K Rajewsky
Journal:  J Exp Med       Date:  2000-08-07       Impact factor: 14.307

Review 5.  Apoptosis in brain-specific autoimmune disease.

Authors:  J Bauer; H Wekerle; H Lassmann
Journal:  Curr Opin Immunol       Date:  1995-12       Impact factor: 7.486

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.